Trading For This Specialty Pharma Company is up Following Second Quarter Results

Trading For This Specialty Pharma Company is up Following Second Quarter Results

Trading For This Specialty Pharma Company is up Following Second Quarter Results By: Dylan Sikes – AllPennyStocks.com News

Thursday, August 10, 2023

This stock is almost a penny stock no longer, as shares moved close to the $5 threshold following the firm’s quarterly announcement. Leading pan-American (ex-US) specialty pharmaceutical firm Knight Therapeutics Inc. (TSX: GUD) today reported financial results for its second quarter ended June 30, 2023 in a press release today. 

Headquartered in Montreal, Canada, Knight Pharmaceuticals is focuses on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Second-quarter result highlights included a 19 percent annual increase in revenues as well as several products submitted for regulatory revenue in South America and an approval in Chile.

Shares were trading up after the opening bell at $4.89 per share.


Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Oil & Gas Explorer Inks Major Acquisition Agreement With Mexican Firm, Shares Rally
Healthcare Shares Soar Following Major Price Target Increase
EV & EV-Adjacent Shares On The Move To Continue Monday's Success
Most Popular
FREE Newsletter


Back to Top